Cargando…

Association between 25-hydroxyvitamin D levels and COVID-19 severity

BACKGROUND AND AIMS: Despite reports on the impact of vitamin D status on coronavirus disease 2019 (COVID-19) severity, the association between low vitamin D status and severe COVID-19 remains unclear. Moreover, researchers have not determined the aforementioned association in Japanese patients. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takase, Tomoki, Tsugawa, Naoko, Sugiyama, Takayuki, Ikesue, Hiroaki, Eto, Masaaki, Hashida, Tohru, Tomii, Keisuke, Muroi, Nobuyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism. 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8994250/ https://www.ncbi.nlm.nih.gov/pubmed/35623823 http://dx.doi.org/10.1016/j.clnesp.2022.04.003

Ejemplares similares

Population pharmacokinetics and exposure–clinical outcome relationship of remdesivir major metabolite GS‐441524 in patients with moderate and severe COVID‐19
por: Tamura, Ryo, et al.
Publicado: (2023)

Pharmacokinetics of Favipiravir in Critically Ill Patients With COVID‐19
por: Irie, Kei, et al.
Publicado: (2020)

Population pharmacokinetics of favipiravir in patients with COVID‐19
por: Irie, Kei, et al.
Publicado: (2021)

Population Pharmacokinetics of Nivolumab in Japanese Patients with Nonsmall Cell Lung Cancer
por: Tohi, Makiko, et al.
Publicado: (2023)

Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban
por: Takase, Tomoki, et al.
Publicado: (2019)

Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma
por: Yamaoka, Kenta, et al.
Publicado: (2023)

Safety and efficacy evaluation of low-dose trimethoprim-sulfamethoxazole for prophylaxis of Pneumocystis pneumonia in HIV uninfected patients undergoing hemodialysis: a retrospective observational study
por: Yamashita, Kanae, et al.
Publicado: (2021)

Evaluation of the usefulness of protocol‐based pharmacist‐facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer
por: Ikesue, Hiroaki, et al.
Publicado: (2020)

Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Evaluating the safety and efficiency of robotic dispensing systems
por: Takase, Tomoki, et al.
Publicado: (2022)

Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone
por: Satsuma, Yukari, et al.
Publicado: (2020)

Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery
por: Takase, Tomoki, et al.
Publicado: (2018)

Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score–matched analysis
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Polypharmacy-associated potential contraindications of drug prescriptions in patients with primary angle closure disease in a real-world setting
por: Tanaka, Fumiaki, et al.
Publicado: (2021)

Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases
por: Ikesue, Hiroaki, et al.
Publicado: (2021)

Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib
por: Ikesue, Hiroaki, et al.
Publicado: (2022)

Pharmacist-Urologist Collaborative Management Improves Clinical Outcomes in Patients With Castration-Resistant Prostate Cancer Receiving Enzalutamide
por: Hirabatake, Masaki, et al.
Publicado: (2022)

Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication
por: Tanaka, Fumiaki, et al.
Publicado: (2023)

Correlation between Serum 25-Hydroxyvitamin D Levels with Keloid Severity
por: Damanik, Vira Indhiratamin, et al.
Publicado: (2019)

25-Hydroxyvitamin D and Severity of Parkinson's Disease
por: Chitsaz, Ahmad, et al.
Publicado: (2013)

Comparison of Vitamin D and 25-Hydroxyvitamin D Concentrations in Human Breast Milk between 1989 and 2016–2017
por: Tsugawa, Naoko, et al.
Publicado: (2021)

The relationship between low maternal serum 25-hydroxyvitamin D levels and gestational diabetes mellitus according to the severity of 25-hydroxyvitamin D deficiency
por: Zuhur, Sayid Shafi, et al.
Publicado: (2013)

Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database
por: Hasegawa, Shiori, et al.
Publicado: (2022)

Association between bruxism severity and serum concentrations of 25‐hydroxyvitamin D levels
por: Allaf, Bushra A. W., et al.
Publicado: (2022)

Associations between serum 25-hydroxyvitamin D(3) level and skeletal muscle mass and lower limb muscle strength in Japanese middle-aged subjects
por: Kuwabara, Akiko, et al.
Publicado: (2017)

Mammographic density and serum 25-hydroxyvitamin D levels
por: Crew, Katherine D, et al.
Publicado: (2014)

The serum level of 25-hydroxyvitamin D for maximal suppression of parathyroid hormone in children: the relationship between 25-hydroxyvitamin D and parathyroid hormone
por: Kang, Jung In, et al.
Publicado: (2017)

Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer
por: Ren, Chao, et al.
Publicado: (2012)

Serum 25-Hydroxyvitamin D Levels in Pediatric Burn Patients
por: Sobouti, Behnam, et al.
Publicado: (2016)

Evaluation of 25-Hydroxyvitamin D Levels in Central Anatolia, Turkey
por: Solak, Ibrahim, et al.
Publicado: (2018)

Decreased 25-Hydroxyvitamin D Levels in Patients With Vestibular Neuritis
por: Wu, Yunqin, et al.
Publicado: (2019)

Assessment of 25-Hydroxyvitamin D Levels in Patients with Resistant Hypertension
por: Belen, Erdal, et al.
Publicado: (2015)

Influence of the Mediterranean Diet on 25-Hydroxyvitamin D Levels in Adults
por: Barrea, Luigi, et al.
Publicado: (2020)

Low serum 25‐hydroxyvitamin D levels are associated with perennial allergic rhinitis but not disease severity
por: Ma, Yan, et al.
Publicado: (2020)

Pre-infection 25-hydroxyvitamin D3 levels and association with severity of COVID-19 illness
por: Dror, Amiel A., et al.
Publicado: (2022)

Is Serum 25-Hydroxyvitamin D Level Associated with Severity of COVID-19? A Retrospective Study
por: Mbata, Munachimso Kizito, et al.
Publicado: (2023)

Discrepant association of serum C-3 epimer of 25-hydroxyvitamin D versus non-epimeric 25-hydroxyvitamin D with serum lipid levels
por: Chailurkit, La-or, et al.
Publicado: (2016)

Relationship between serum 25-hydroxyvitamin D and interleukin-31 levels, and the severity of atopic dermatitis in children
por: Cheon, Bo Ram, et al.
Publicado: (2015)

The relationship between serum 25-hydroxyvitamin D levels and the severity of COVID-19 disease and its mortality
por: Vasheghani, Maryam, et al.
Publicado: (2021)

Relationships between 25-Hydroxyvitamin D Levels and Obstructive Sleep Apnea Severity in Children: An Observational Study
por: Locci, Cristian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_46mmt16csg1rhjhrhg8dr909f8